| Literature DB >> 27189675 |
John M Keith1, Mark S Tichenor2, Richard L Apodaca2, Wei Xiao2, William M Jones2, Mark Seierstad2, Joan M Pierce2, James A Palmer2, Michael Webb2, Mark J Karbarz2, Brian P Scott2, Sandy J Wilson2, Michelle L Wennerholm2, Michele Rizzolio2, Raymond Rynberg2, Sandra R Chaplan2, J Guy Breitenbucher2.
Abstract
The SAR of brain penetration for a series of heteroaryl piperazinyl- and piperadinyl-urea fatty acid amide hydrolase (FAAH) inhibitors is described. Brain/plasma (B/P) ratios ranging from >4:1 to as low as 0.02:1 were obtained through relatively simple structural changes to various regions of the heteroaryl urea scaffold. It was not possible to predict the degree of central nervous system (CNS) penetration from the volumes of distribution (Vd) obtained from pharmacokinetic (PK) experiments as very high Vds did not correlate with high B/P ratios. Similarly, calculated topological polar surface areas (TPSAs) did not consistently correlate with the degree of brain penetration. The lowest B/P ratios were observed for those compounds that were significantly ionized at physiological pH. However, as this class of compounds inhibits the FAAH enzyme through covalent modification, low B/P ratios did not preclude effective central target engagement.Entities:
Keywords: BBB; Blood brain barrier; Covalent inhibition; FAAH; Heteroaryl urea; Rat PK; Target engagement
Mesh:
Substances:
Year: 2016 PMID: 27189675 DOI: 10.1016/j.bmcl.2016.05.001
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823